June 3, 2021

Synchron Secures $40M in Series B led by Khosla Ventures to Launch U.S. Clinical Trials of Minimally Invasive Brain Computer Interface

NEW YORK–(BUSINESS WIRE)–Synchron, a brain interface platform company, today announced that the company has secured $40M in a Series B round of financing led by Silicon Valley venture capital firm Khosla Ventures. Synchron is the leader in minimally invasive implantable brain computer interface (BCI) technology, which utilizes the jugular vein to access the brain. Synchron has already commenced a clinical trial in Australia that has so far enrolled four patients with paralysis who have underg


Leave Comment


Your Name *
Your Email *
Your Website
Comment *